Patient Support Line 1-866-433-8000, Monday - Friday: 8:00 AM to 8:00 PM ET
Frequently Asked Questions
Questions and answers about KISQALI
Click below for answers to some of the most frequently asked questions about KISQALI.
KISQALI is a prescription medicine used to treat adults with HR+, HER2- breast cancer in combination with an aromatase inhibitor for stage II and III early breast cancer with a high risk of coming back.
KISQALI is not chemotherapy. KISQALI is a targeted therapy called a CDK4/6 inhibitor. By blocking CDK4 and CDK6 proteins, KISQALI can help keep new cancer cells from forming.
KISQALI is a targeted treatment for HR+, HER2- eBC with a high risk of returning that blocks, or interferes with, substances that can cause cancer to return. KISQALI affects cancer cells, but can also affect healthy cells.
Learn how KISQALI and hormone therapy work together to help reduce the risk of cancer returning.
KISQALI has been proven to significantly reduce the risk of cancer returning vs hormone therapy alone.
The most common side effects of KISQALI are decreased white blood cell counts, increased liver function tests, decreased red blood cell counts, infections, increased kidney function test, decreased platelet counts, nausea, headache, and tiredness. KISQALI can also cause more serious side effects.
Learn more about the potential side effects of KISQALI.
Your health care team may offer suggestions to help manage some of the side effects of KISQALI. It’s important to talk with your doctor or nurse about side effects you experience and the best ways to manage them.
KISQALI is a prescription medicine that is a convenient once-daily oral tablet that comes in an easy-to-use blister pack. Your doctor will prescribe the dose of KISQALI that's right for you. You should take KISQALI exactly as your health care provider tells you. Take KISQALI each day at about the same time, preferably in the morning. Do not change your dose or stop taking KISQALI unless your health care provider tells you. You may take KISQALI with or without food. Ask your doctor about the recommended dose of your aromatase inhibitor.
If you miss a dose of KISQALI or vomit after taking a dose of KISQALI, do not take another dose on that day. Take your next dose at your regular time.
Avoid eating grapefruit and avoid drinking grapefruit juice. Be sure to share a list of any medications, vitamins, or herbal supplements you are currently taking with your doctor. It's important to make sure all of your medications work safely together.
Novartis Pharmaceuticals Corporation is committed to helping make treatment with KISQALI as affordable as possible.
Novartis Patient Support™ is a comprehensive program to help you start, stay, and save on your KISQALI treatment.
Learn important information and tips on how to work with your doctor to manage potential side effects